Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
The closing price of Everus Construction Group (NYSE: ECG) was $59.79 for the day, up 0.07% from the previous closing price of $59.75. In other words, the price has increased by $0.07 from its previous closing price. On the day, 0.34 million shares were traded. ECG stock price reached its highest trading level at $61.57 during the session, while it also had its lowest trading level at $59.26.
Ratios:
Our analysis of ECG’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 1.69 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.69.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on December 04, 2024, initiated with a Outperform rating and assigned the stock a target price of $70.
On November 15, 2024, Stifel started tracking the stock assigning a Buy rating and target price of $71.Stifel initiated its Buy rating on November 15, 2024, with a $71 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Feb 25 ’25 when Marcy Maximillian J bought 1,300 shares for $38.99 per share. The transaction valued at 50,694 led to the insider holds 5,508 shares of the business.
Ryan Edward A bought 1,400 shares of ECG for $53,235 on Feb 25 ’25. The Director now owns 14,928 shares after completing the transaction at $38.02 per share. On Feb 18 ’25, another insider, DELLA ROCCA MICHAEL, who serves as the Director of the company, bought 1,050 shares for $47.56 each. As a result, the insider paid 49,943 and bolstered with 2,027 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ECG now has a Market Capitalization of 3049266176 and an Enterprise Value of 3335641856. As of this moment, Everus’s Price-to-Earnings (P/E) ratio for their current fiscal year is 20.08, and their Forward P/E ratio for the next fiscal year is 20.88. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.00 while its Price-to-Book (P/B) ratio in mrq is 6.63. Its current Enterprise Value per Revenue stands at 1.093 whereas that against EBITDA is 14.618.
Stock Price History:
Over the past 52 weeks, ECG has reached a high of $77.93, while it has fallen to a 52-week low of $31.38. The 50-Day Moving Average of the stock is 18.37%, while the 200-Day Moving Average is calculated to be 9.12%.
Shares Statistics:
ECG traded an average of 643.46K shares per day over the past three months and 292770 shares per day over the past ten days. A total of 51.00M shares are outstanding, with a floating share count of 50.72M. Insiders hold about 0.55% of the company’s shares, while institutions hold 78.96% stake in the company. Shares short for ECG as of 1748563200 were 1681951 with a Short Ratio of 2.61, compared to 1745971200 on 2037648. Therefore, it implies a Short% of Shares Outstanding of 1681951 and a Short% of Float of 4.29.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Everus Construction Group (ECG) is presently subject to a detailed evaluation by 3 analysts, each offering their unique perspectives on its market standing.The consensus estimate for the next quarter is $0.65, with high estimates of $0.72 and low estimates of $0.6.
Analysts are recommending an EPS of between $2.72 and $2.48 for the fiscal current year, implying an average EPS of $2.57. EPS for the following year is $2.92, with 4.0 analysts recommending between $3.1 and $2.69.
Revenue Estimates
For the next quarter, 3 analysts are estimating revenue of $784.87M. There is a high estimate of $791M for the next quarter, whereas the lowest estimate is $773.12M.
A total of 3 analysts have provided revenue estimates for ECG’s current fiscal year. The highest revenue estimate was $3.11B, while the lowest revenue estimate was $3.07B, resulting in an average revenue estimate of $3.1B. In the same quarter a year ago, actual revenue was $2.85BBased on 3 analysts’ estimates, the company’s revenue will be $3.41B in the next fiscal year. The high estimate is $3.69B and the low estimate is $3.27B.
